IMMUNOREACTIVE HEPATOCYTE GROWTH-FACTOR IS PRESENT IN TISSUE-EXTRACTS FROM HUMAN BREAST-CANCER BUT NOT IN CONDITIONED MEDIUM OF HUMAN BREAST-CANCER CELL-LINES

被引:0
|
作者
YAMASHITA, J [1 ]
OGAWA, M [1 ]
BEPPU, T [1 ]
机构
[1] KUMAMOTO UNIV,SCH MED,DEPT SURG 2,HONJO 1-1-1,KUMAMOTO 860,JAPAN
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepatocyte growth factor (HGF) is a novel mitogen for mature hepatocytes. In the present study, we have measured immunoreactive (ir)-HGF concentration in tumor extracts of 82 primary human breast cancers using an enzyme-linked immunosorbent assay (ELISA). Ir-HGF was detectable in all tissue extracts, the concentration ranging from 1.4 to 306.5 ng/100 mg protein (median value: 11.2 ng/100 mg protein). Correlation analyses between ir-HGF concentration and clinicopathological factors showed that the ir-HGF level was significantly higher in tumors with sizes of more than 5.0 cm compared with those less than 5.0 cm. In contrast, no detectable amount of ir-HGF was secreted into culture medium of two breast cancer cell lines, MCF-7 and ZR-751, suggesting that the cancer cell itself has no ability to produce ir-HGF.
引用
收藏
页码:249 / 252
页数:4
相关论文
共 50 条
  • [1] CELLULAR-LOCALIZATION OF TISSUE FACTOR IN HUMAN BREAST-CANCER CELL-LINES
    MULLER, M
    FLOSSEL, C
    HAASE, M
    LUTHER, T
    ALBRECHT, S
    NAWROTH, PP
    ZHANG, YM
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1993, 64 (05) : 265 - 269
  • [2] IMMUNOREACTIVE HEPATOCYTE GROWTH-FACTOR IS A STRONG AND INDEPENDENT PREDICTOR OF RECURRENCE AND SURVIVAL IN HUMAN BREAST-CANCER
    YAMASHITA, J
    OGAWA, M
    YAMASHITA, S
    NOMURA, K
    KURAMOTO, M
    SAISHOJI, T
    SHIN, S
    CANCER RESEARCH, 1994, 54 (07) : 1630 - 1633
  • [3] IMMUNOREACTIVE ALPHA-TRANSFORMING GROWTH-FACTOR IN HUMAN-BREAST TUMOR EXTRACTS AND IN HUMAN-BREAST CANCER CELL-LINES
    PERROTEAU, I
    KIDWELL, WR
    PARDUE, R
    DEBORTOLI, M
    SALOMON, D
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 166 - 166
  • [4] NEW CELL-LINES OF HUMAN BREAST-CANCER ORIGIN
    CALAF, G
    ABARCAQUINONES, J
    FEUILHADE, F
    BEAUNE, J
    DUPRE, G
    ORRICO, M
    BARNABASSOHI, N
    KOUYOUMDJIAN, JC
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 21 (01) : 63 - 75
  • [5] PRODUCTION OF PDGF-LIKE GROWTH-FACTOR BY BREAST-CANCER CELL-LINES
    ROZENGURT, E
    SINNETTSMITH, J
    TAYLORPAPADIMITRIOU, J
    INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (02) : 247 - 252
  • [6] GROWTH-FACTOR SYNTHESIS AND HUMAN BREAST-CANCER PROGRESSION
    ETHIER, SP
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (13) : 964 - 973
  • [7] DIFFERENTIATION STATE AND INVASIVENESS OF HUMAN BREAST-CANCER CELL-LINES
    SOMMERS, CL
    BYERS, SW
    THOMPSON, EW
    TORRI, JA
    GELMANN, EP
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (2-3) : 325 - 335
  • [8] OXYTOCIN INHIBITS PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES
    CASSONI, P
    SAPINO, A
    NEGRO, F
    BUSSOLATI, G
    VIRCHOWS ARCHIV, 1994, 425 (05) : 467 - 472
  • [9] COMBINED EFFECTS OF LONIDAMINE AND TAMOXIFEN IN HUMAN BREAST-CANCER CELL-LINES
    GORNATI, D
    ZAFFARONI, N
    ORLANDI, L
    DIFRONZO, G
    SILVESTRINI, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (05) : 993 - 996
  • [10] MECHANISMS OF RESISTANCE TO ANSAMYCIN ANTIBIOTICS IN HUMAN BREAST-CANCER CELL-LINES
    BENCHEKROUN, MN
    SCHNEIDER, E
    SAFA, AR
    TOWNSEND, AJ
    SINHA, BK
    MOLECULAR PHARMACOLOGY, 1994, 46 (04) : 677 - 684